Asset Details
Do you wish to reserve the book?
Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy
Do you wish to request the book?
Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy
2025
Overview
In a randomized trial, once-weekly insulin efsitora, administered in a fixed-dose regimen, was noninferior to once-daily glargine in reducing hemoglobin levels in patients with type 2 diabetes who had not previously received insulin.
Publisher
Massachusetts Medical Society
Subject
/ Aged
/ Aging
/ Dementia
/ Diabetes
/ Diabetes mellitus (non-insulin dependent)
/ Diabetes Mellitus, Type 2 - blood
/ Diabetes Mellitus, Type 2 - drug therapy
/ Drug Administration Schedule
/ Fasting
/ Female
/ Glucose
/ Glycated Hemoglobin - analysis
/ Humans
/ Hypoglycemia - chemically induced
/ Hypoglycemic Agents - administration & dosage
/ Hypoglycemic Agents - adverse effects
/ Insulin
/ Insulin Glargine - administration & dosage
/ Insulin Glargine - adverse effects
/ Insulin, Long-Acting - administration & dosage
/ Insulin, Long-Acting - adverse effects
/ Insulins
/ Male
/ Outpatient-Based Clinical Medicine
/ Recombinant Fusion Proteins - administration & dosage
